Tim F. Greten

United States Department of Health and Human Services

Also affiliated with National Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 73 papers. Top paper: “A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma”.

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

The Oncologist(2022)10.1093/oncolo/oyab073

N/A

1.5DataRank · unranked

44 citations

Erica C. Pehrsson, Changqing Xie, Austin G. Duffy, Donna Mabry, Bradford J. Wood +10 more

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005640

N/A

1.4DataRank · unranked

72 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang +15 more

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Science(2017)10.1126/science.aan6733

N/A

1.3DataRank · unranked

6550 citations

Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh +46 more

Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma

Radiology(2024)10.1148/radiol.232875

N/A

0.618DataRank · unranked

19 citations

Riad Salem, Richard S. Finn, Tim F. Greten, S. Nahum Goldberg, Julius Chapiro +1 more

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

Gut(2025)10.1136/gutjnl-2024-334026

N/A

0.567DataRank · unranked

18 citations

Sepideh Babaei, Rajiv Trehan, Christoph Hoffman, Noémi Kedei, Benjamin Ruf +33 more

Lineage and ecology define liver tumor evolution in response to treatment

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101394

N/A

0.503DataRank · unranked

11 citations

Limin Wang, Marshonna Forgues, Shay Behrens, Amanda J. Craig, Meng Liu +9 more

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008079

N/A

0.470DataRank · unranked

11 citations

Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J. Wood +7 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cancer Medicine(2024)10.1002/cam4.6912

N/A

0.450DataRank · unranked

12 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Gagandeep Brar +12 more

Innate protection against intrarectal SIV acquisition by a live SHIV vaccine

JCI Insight(2024)10.1172/jci.insight.175800

N/A

0.184DataRank · unranked

2 citations

Thomas J. Meyer, Christine M. Fennessey, Brandon F. Keele, Kimia Dadkhah, Chi Ma +16 more

Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models

iScience(2020)10.1016/j.isci.2020.101990

N/A

0DataRank · unranked

25 citations

John C. McVey, Chi Ma, Benjamin Ruf, Olena Kamenyeva, Justin McCallen +4 more

Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma

Journal of Liver Cancer(2020)10.17998/jlc.20.1.1

N/A

0DataRank · unranked

7 citations

Tim F. Greten, Su Jong Yu

Loss of myeloid‐specific lamin A/C drives lung metastasis through Gfi‐1 and C/EBPε‐mediated granulocytic differentiation

Molecular Carcinogenesis(2020)10.1002/mc.23147

N/A

0DataRank · unranked

4 citations

Woo‐Yong Park, Jae-Young So, Skyler A. Kuhn, Vishal N. Koparde, Yanli Pang +4 more

A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.117

N/A

0DataRank · unranked

19 citations

Changqing Xie, Seth M. Steinberg, Suzanne Fioraventi, Melissa Walker, Donna Mabry‐Hrones +4 more

Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4656

N/A

0DataRank · unranked

4 citations

Changqing Xie, Donna Mabry‐Hrones, Bradford J. Wood, Seth M. Steinberg, David E. Kleiner +2 more

Long-term survival of combined ablation therapy and tremelimumab with or without durvalumab in advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16689

N/A

0DataRank · unranked

1 citations

Changqing Xie, John C. McVey, Donna Mabry‐Hrones, Austin G. Duffy, Bradford J. Wood +2 more

Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epitope, for operable CA 19-9 producing pancreatic cancers, cholangiocarcinomas, and metastatic colorectal cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4655

N/A

0DataRank · unranked

1 citations

James D. McDonald, Reed I. Ayabe, Tahsin M. Khan, Lauren A. Gamble, Alexander J. Rossi +9 more

Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Journal of Hepatology(2021)10.1016/j.jhep.2021.06.028

N/A

0DataRank · unranked

387 citations

Limin Wang, Subreen A. Khatib, Ching-Wen Chang, S. Heinrich, Dana A. Dominguez +13 more

Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma

Nature Communications(2021)10.1038/s41467-021-21804-1

N/A

0DataRank · unranked

243 citations

Joo Sang Lee, Chi Ma, Laurence P. Diggs, S. Heinrich, Ching-Wen Chang +9 more

The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma

Gut(2021)10.1136/gutjnl-2021-325288

N/A

0DataRank · unranked

116 citations

E. Michael Gertz, Alejandro A. Schäffer, Amanda J. Craig, Benjamin Ruf, Varun Subramanyam +22 more

MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target

Cellular Immunology(2021)10.1016/j.cellimm.2021.104295

N/A

0DataRank · unranked

80 citations

Qianfei Zhang, Tim F. Greten, Chi Ma

Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0925

N/A

0DataRank · unranked

63 citations

Vanessa V. Catania, Simon Wabitsch, Chi Ma, Laurence P. Diggs, Qianfei Zhang +12 more

Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.05.011

N/A

0DataRank · unranked

47 citations

Mayank Tandon, Benjamin Ruf, Qianfei Zhang, Justin McCallen, John C. McVey +6 more

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s311496

N/A

0DataRank · unranked

18 citations

Changqing Xie, Seth M. Steinberg, Tim F. Greten, Cecilia Monge

Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro

STAR Protocols(2021)10.1016/j.xpro.2021.100517

N/A

0DataRank · unranked

0 citations

Justin McCallen, Chi Ma, Tim F. Greten, Simon Wabitsch

Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer

Nature Communications(2022)10.1038/s41467-022-35291-5

N/A

0DataRank · unranked

158 citations

S. Heinrich, Limin Wang, Friederike L. Keggenhoff, Subreen A. Khatib, Marshonna Forgues +12 more

Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD

Journal of Hepatology(2022)10.1016/j.jhep.2022.03.010

N/A

0DataRank · unranked

144 citations

Justin McCallen, Olena Kamenyeva, Benjamin Ruf, John C. McVey, Juraj Kabát +15 more

Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD

Cancer Cell(2022)10.1016/j.ccell.2022.08.004

N/A

0DataRank · unranked

111 citations

Qiong Fu, Laurence P. Diggs, John C. McVey, Justin McCallen, Simon Wabitsch +17 more

The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis

Trends in cancer(2022)10.1016/j.trecan.2022.02.009

N/A

0DataRank · unranked

62 citations

Steve Bilodeau, Tim F. Greten, Sophie Wang, Giorgio Trinchieri, Maruhen Amir Datsch Silveira

MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

Cell Reports Methods(2022)10.1016/j.crmeth.2021.100136

N/A

0DataRank · unranked

27 citations

Bryce Killingsworth, Julia Kepley, Tim Traynor, Sean Cook, Jason E. Savage +32 more

NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice

iScience(2022)10.1016/j.isci.2022.103847

N/A

0DataRank · unranked

23 citations

Benjamin L. Green, Benjamin Ruf, Justin McCallen, Simon Wabitsch, Varun Subramanyam +5 more

Interventional radiology meets immuno-oncology for hepatocellular carcinoma

Journal of Hepatology(2022)10.1016/j.jhep.2022.08.003

N/A

0DataRank · unranked

20 citations

Tim F. Greten, Riad Salem

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.849958

N/A

0DataRank · unranked

10 citations

Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W. Lai, Amanda J. Craig +6 more

1019 CSF1R+PD-L1+ tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1019

N/A

0DataRank · unranked

0 citations

Matthias Bruhns, Sepideh Babaei, Noémi Kedei, Chi Ma, Lichun Ma +27 more

Immunology and immunotherapy of cholangiocarcinoma

Nature Reviews Gastroenterology & Hepatology(2023)10.1038/s41575-022-00741-4

N/A

0DataRank · unranked

186 citations

Robert F. Schwabe, Nabeel Bardeesy, Lichun Ma, Lipika Goyal, Robin Kate Kelley +2 more

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Cell(2023)10.1016/j.cell.2023.07.026

N/A

0DataRank · unranked

174 citations

Matthias Bruhns, Sepideh Babaei, Noémi Kedei, Lichun Ma, Mahler Revsine +32 more

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z

N/A

0DataRank · unranked

121 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity

Nature reviews. Cancer(2023)10.1038/s41568-023-00562-w

N/A

0DataRank · unranked

112 citations

Tim F. Greten, Firouzeh Korangy, Benjamin Ruf

Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing

Cell Reports(2023)10.1016/j.celrep.2023.113446

N/A

0DataRank · unranked

30 citations

Maruhen Amir Datsch Silveira, Lichun Ma, Mahler Revsine, Limin Wang, S. Heinrich +19 more

The current landscape of therapies for hepatocellular carcinoma

Carcinogenesis(2023)10.1093/carcin/bgad052

N/A

0DataRank · unranked

28 citations

Changqing Xie, Donna Mabry Hrones, Shadin Ghabra, Tim F. Greten, Cecilia Monge +1 more

Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years

Cancer Medicine(2023)10.1002/cam4.6814

N/A

0DataRank · unranked

21 citations

Tim F. Greten, Cecilia Monge

Immunosuppressive CD29 + Treg accumulation in the liver in mice on checkpoint inhibitor therapy

Gut(2023)10.1136/gutjnl-2023-330024

N/A

0DataRank · unranked

17 citations

Yuta Myojin, Chi Ma, Benjamin Ruf, Lichun Ma, Qianfei Zhang +15 more

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101052

N/A

0DataRank · unranked

31 citations

Erica C. Pehrsson, Aiwu Ruth He, Lipika Goyal, Robin Kate Kelley, Hien Dang +26 more

Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States

Journal of Hepatocellular Carcinoma(2023)10.2147/jhc.s412446

N/A

0DataRank · unranked

14 citations

J. Alberto Maldonado, Katherine A. McGlynn, Tim F. Greten, Cecilia Monge

The Microbiome and Liver Cancer

The Cancer Journal(2023)10.1097/ppo.0000000000000646

N/A

0DataRank · unranked

12 citations

Tim F. Greten, Yuta Myojin

Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m6A-mediated epitranscriptomic regulation

Hepatology(2023)10.1097/hep.0000000000000420

N/A

0DataRank · unranked

10 citations

Ching-Wen Chang, Kathy Cheng Wang, Jittiporn Chaisaingmongkol, Mathuros Ruchirawat, Tim F. Greten +2 more

CSF-1R+ Macrophages Control the Gut Microbiome–Enhanced Liver Invariant NKT Function through IL-18

The Journal of Immunology(2023)10.4049/jimmunol.2200854

N/A

0DataRank · unranked

8 citations

Justin McCallen, John C. McVey, Rajiv Trehan, Kylynda C. Bauer, Qianfei Zhang +8 more

Top advances of the year: Hepatobiliary cancers

Cancer(2023)10.1002/cncr.34652

N/A

0DataRank · unranked

5 citations

Tim F. Greten, Kelley Coffman

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps624

N/A

0DataRank · unranked

18 citations

M. Cecilia Monge B., Donna Mabry‐Hrones, Kelley Coffman, Stephanie N. Hicks, Bernadette Redd +5 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16158

N/A

0DataRank · unranked

2 citations

Kelley Coffman, Donna Mabry Hrones, Seth M. Steinberg, Bernadette Redd, Bradford J. Wood +3 more

Cost-effectiveness of gemcitabine plus cisplatin with and without durvalumab in patients with advanced cholangiocarcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.498

N/A

0DataRank · unranked

1 citations

Tim F. Greten, M. Cecilia Monge B., J. Alberto Maldonado

Data from Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response

(2023)10.1158/2326-6066.c.6550414.v1

N/A

0DataRank · unranked

0 citations

Vanessa V. Catania, Simon Wabitsch, Chi Ma, Laurence P. Diggs, Qianfei Zhang +12 more

Supplementary Tables from Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response

(2023)10.1158/2326-6066.22543810

N/A

0DataRank · unranked

0 citations

Vanessa V. Catania, Simon Wabitsch, Chi Ma, Laurence P. Diggs, Qianfei Zhang +12 more

Innate-like T cells in liver disease

Trends in Immunology(2024)10.1016/j.it.2024.05.008

N/A

0DataRank · unranked

28 citations

Kilian Wistuba‐Hamprecht, Tim F. Greten, Benjamin Ruf, Albert Ying-Po Yang

Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States

Journal of Racial and Ethnic Health Disparities(2024)10.1007/s40615-024-02178-8

N/A

0DataRank · unranked

10 citations

Tim F. Greten, Cecilia Monge, Gabriela Arroyo Figueroa

Protocol for establishing liver tumors via ultrasound-guided intrahepatic injection prior partial hepatic resection in a mouse model

STAR Protocols(2024)10.1016/j.xpro.2024.103341

N/A

0DataRank · unranked

2 citations

Rajiv Trehan, Francisco Rodríguez-Matos, Chi Ma, Tim F. Greten, Shadin Ghabra

Quantifying morphologic variations as an alternate to standard response criteria for unresectable primary liver tumors after checkpoint inhibition therapy

La radiologia medica(2024)10.1007/s11547-024-01937-1

N/A

0DataRank · unranked

2 citations

Nicole Varble, Tabea Borde, Andrew S. Mikhail, Michael Kassin, Elliot Levy +11 more

Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy

Methods and Protocols(2024)10.3390/mps7060099

N/A

0DataRank · unranked

3 citations

Shadin Ghabra, Chi Ma, Lee Chedester, Tim F. Greten, Kylynda C. Bauer

The Gut Microbiome Controls Liver Tumors via the Vagus Nerve

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.23.576951

N/A

0DataRank · unranked

15 citations

Rajiv Trehan, Benjamin Ruf, Yuta Myojin, Mohamed-Reda Benmebarek, Chi Ma +20 more

A Paradoxical Tumor Antigen Specific Response in the Liver

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.19.614002

N/A

0DataRank · unranked

0 citations

Xiao Bin Zhu, Patrick Huang, Sophie Wang, Marlaine Soliman, Dillon Strepay +10 more

SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases

Nature Communications(2025)10.1038/s41467-025-59529-0

N/A

0DataRank · unranked

52 citations

Patrick Huang, Xiao Bin Zhu, Xin Wang, Marlaine Soliman, Dillon Strepay +10 more

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

Cancer Cell(2025)10.1016/j.ccell.2025.02.010

N/A

0DataRank · unranked

48 citations

Antonin Lévy, Ai-Ling Tian, Xuehan Huang, Guoxin Cai, Marine Fidelle +56 more

Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME

Immunity(2025)10.1016/j.immuni.2025.02.017

N/A

0DataRank · unranked

33 citations

Cihan Oguz, Matthias Seifert, Benjamin Ruf, Yuta Myojin, Kylynda C. Bauer +20 more

Hepatic immune environment differences among common mouse strains in models of MASH and liver cancer

JHEP Reports(2025)10.1016/j.jhepr.2025.101380

N/A

0DataRank · unranked

4 citations

Francisco Rodríguez-Matos, Jonathan Qi, Rajiv Trehan, Yuta Myojin, Xiao Bin Zhu +3 more

Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers

Cancer Letters(2025)10.1016/j.canlet.2025.217975

N/A

0DataRank · unranked

3 citations

Joy Awosika, Cecilia Monge, Kelley Coffman, Changqing Xie, Nebojša Skorupan +13 more

Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011742

N/A

0DataRank · unranked

0 citations

Whitney Leet, Limin Wang, Mahler Revsine, Evan Maestri, Aleesha R. Jacob +10 more

Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice

Gastroenterology(2020)10.1053/j.gastro.2020.02.011

N/A

0DataRank · unranked

163 citations

Nan Li, Yifan Zhang, Haiying Fu, Mingqian Feng, Dina Schneider +22 more

CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma

Journal of Hepatology(2020)10.1016/j.jhep.2020.11.037

N/A

0DataRank · unranked

148 citations

Benjamin Ruf, Chi Ma, Bernd Heinrich, Linda L. Cui, Qianfei Zhang +16 more

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Hepatology(2020)10.1002/hep.31327

N/A

0DataRank · unranked

414 citations

Augusto Villanueva, Jorge A. Marrero, Myron E. Schwartz, Tim Meyer, Peter R. Galle +9 more

Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells

Cellular and Molecular Immunology(2020)10.1038/s41423-020-00572-w

N/A

0DataRank · unranked

334 citations

Bernd Heinrich, Tim F. Greten, Benjamin Ruf

Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0304

N/A

0DataRank · unranked

251 citations

Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P. Diggs +24 more

Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3624

N/A

0DataRank · unranked

101 citations

Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry‐Hrones, Melissa Walker +14 more

A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma

Cell(2020)10.1016/j.cell.2020.05.038

N/A

0DataRank · unranked

87 citations

Wei Tang, Anuradha Budhu, Marshonna Forgues, Maria O. Hernandez, Julián Candia +17 more

Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice

Gastroenterology(2020)10.1053/j.gastro.2020.09.031

N/A

0DataRank · unranked

79 citations

Zachary J. Brown, Laurence P. Diggs, Mathias Vormehr, Chi Ma, Varun Subramanyam +12 more